Interestingly, Kaplan–Meier analysis for BCR, bone metastasis, and prostate cancer-specific survival showed that elevated expression of G3PP is a predictive biomarker of early relapse and poor prognosis. This evidence concerns the gene PGP and prostate carcinoma.